000462596 000__ 01404cam\a2200349\a\4500
000462596 001__ 462596
000462596 005__ 20210513162035.0
000462596 006__ m\\\\\\\\d\\\\\\\\
000462596 007__ cr\cn|||||||||
000462596 008__ 120907s2012\\\\gw\a\\\\sb\\\\001\0\eng\d
000462596 020__ $$z9783527333950 (print)
000462596 020__ $$z9783527664481 (e-book)
000462596 035__ $$a(CaPaEBR)ebr10593150
000462596 035__ $$a(OCoLC)811407511
000462596 040__ $$aCaPaEBR$$cCaPaEBR
000462596 05014 $$aRM300$$b.P43 2012eb
000462596 24500 $$aPharmaceuticals$$h[electronic resource] /$$cedited by Jürgen Dinges and Clemens Lamberth.
000462596 260__ $$aWeinheim [Germany] :$$bWiley-VCH,$$cc2012.
000462596 300__ $$axv, 356 p. :$$bill.
000462596 4900_ $$aBioactive heterocyclic compound classes
000462596 504__ $$aIncludes bibliographical references and index.
000462596 5050_ $$apt. 1. Neurological disorders -- pt. 2. Cardiovascular diseases -- pt. 3. Infectious diseases -- pt. 4. Oncology -- pt. 5. Inflammation and gastrointestinal diseases -- pt. 6. Metabolic diseases.
000462596 506__ $$aAccess limited to authorized users.
000462596 650_0 $$aDrugs.
000462596 650_0 $$aBioactive compounds.
000462596 650_0 $$aHeterocyclic compounds.
000462596 655_7 $$aElectronic books.$$2lcsh
000462596 7001_ $$aDinges, Jürgen.
000462596 7001_ $$aLamberth, Clemens.
000462596 852__ $$bebk
000462596 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10593150$$zOnline Access
000462596 909CO $$ooai:library.usi.edu:462596$$pGLOBAL_SET
000462596 980__ $$aEBOOK
000462596 980__ $$aBIB
000462596 982__ $$aEbook
000462596 983__ $$aOnline